
Am J Psychiatry 160:1870-1878, October 2003
© 2003 American Psychiatric Association
Relation of Corpus Callosum and Hippocampal Size to Age in Nondemented Adults With Downs Syndrome
Stefan J. Teipel, M.D.,
Mark B. Schapiro, M.D.,
Gene E. Alexander, Ph.D.,
Jack S. Krasuski, M.D.,
Barry Horwitz, Ph.D.,
Christian Hoehne,
Hans-Jürgen Möller, M.D.,
Stanley I. Rapoport, M.D., and
Harald Hampel, M.D.
OBJECTIVE: Aging in Downs syndrome is accompanied by amyloid and neurofibrillary pathology, the regional and laminar distribution of which resembles pathological changes seen in Alzheimers disease. Previous studies using magnetic resonance imaging (MRI) demonstrated age-related atrophy of medial temporal lobe structures in nondemented older subjects with Downs syndrome, reflecting early allocortical pathology. Corpus callosum atrophy has been established as a marker of neocortical neuronal loss in Alzheimers disease. This study investigated whether atrophy of the corpus callosum and hippocampus occurs in nondemented subjects with Downs syndrome and compared the degree of age-related atrophy between these structures. METHOD: Hippocampus and corpus callosum measures were obtained from volumetric T1-weighted MRI scans of 34 nondemented Downs syndrome adults (mean age=41.6 years, 17 women) and 31 healthy comparison subjects (mean age=41.8 years, 14 women). RESULTS: Downs syndrome subjects had smaller corpus callosum areas and hippocampal volumes relative to age-matched healthy comparison subjects, even after age and total intracranial volume were controlled. There was an age-related decrease of corpus callosum area (most prominent in posterior regions) and hippocampal volume in the Downs syndrome group. The degree of the age effect was comparable between the total corpus callosum and hippocampus, and corpus callosum size was correlated with cognitive performance in the Downs syndrome subjects. There was no correlation between age and corpus callosum or hippocampal size in the comparison group. CONCLUSIONS: Comparable decrease of corpus callosum and hippocampal size with age in nondemented subjects with Downs syndrome suggests that neocortical neuronal alterations accompany allocortical changes in the predementia phase of Downs syndrome.
This article has been cited by other articles:

|
 |

|
 |
 
K. S. Heffernan, J. J. Sosnoff, E. Ofori, S. Y. Jae, T. Baynard, S. R. Collier, S. Goulopoulou, A. Figueroa, J. A. Woods, K. H. Pitetti, et al.
Complexity of force output during static exercise in individuals with Down syndrome
J Appl Physiol,
April 1, 2009;
106(4):
1227 - 1233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Olson, R. J. Roper, C. L. Sengstaken, E. A. Peterson, V. Aquino, Z. Galdzicki, R. Siarey, M. Pletnikov, T. H. Moran, and R. H. Reeves
Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice
Hum. Mol. Genet.,
April 1, 2007;
16(7):
774 - 782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Teipel, G. E. Alexander, M. B. Schapiro, H.-J. Moller, S. I. Rapoport, and H. Hampel
Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry
Brain,
April 1, 2004;
127(4):
811 - 824.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2003
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|